These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1967318

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB, Dombrowski PA, Da Cunha C, Fischer L, Ferraz AC, Lima MM.
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [Abstract] [Full Text] [Related]

  • 44. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
    Harsing LG, Sershen H, Lajtha A.
    J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
    L'hirondel M, Chéramy A, Godeheu G, Artaud F, Saiardi A, Borrelli E, Glowinski J.
    Brain Res; 1998 May 11; 792(2):253-62. PubMed ID: 9593923
    [Abstract] [Full Text] [Related]

  • 47. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA, McCormick P, Kapur S, Willeit M, Garcia A, Hussey D, Houle S, Seeman P, Ginovart N.
    J Med Chem; 2005 Jun 16; 48(12):4153-60. PubMed ID: 15943487
    [Abstract] [Full Text] [Related]

  • 48. Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine.
    Caprathe BW, Jaen JC, Wise LD, Heffner TG, Pugsley TA, Meltzer LT, Parvez M.
    J Med Chem; 1991 Sep 16; 34(9):2736-46. PubMed ID: 1680195
    [Abstract] [Full Text] [Related]

  • 49. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD, Freeman AS, LeWitt PA, Chiodo LA.
    J Pharmacol Exp Ther; 1990 Oct 16; 255(1):276-84. PubMed ID: 1976800
    [Abstract] [Full Text] [Related]

  • 50. Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism.
    Ross SB.
    J Neurochem; 1991 Jan 16; 56(1):22-9. PubMed ID: 1824780
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].
    Martin GE, Williams M, Pettibone DJ, Yarbrough GG, Clineschmidt BV, Jones JH.
    J Pharmacol Exp Ther; 1984 Sep 16; 230(3):569-76. PubMed ID: 6433000
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation.
    Hjorth S, Clark D, Carlsson A.
    Eur J Pharmacol; 1988 Aug 02; 152(3):207-15. PubMed ID: 3146512
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
    Tournier BB, Steimer T, Millet P, Moulin-Sallanon M, Vallet P, Ibañez V, Ginovart N.
    Int J Neuropsychopharmacol; 2013 Sep 02; 16(8):1819-34. PubMed ID: 23574629
    [Abstract] [Full Text] [Related]

  • 59. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes.
    Rinken A, Finnman UB, Fuxe K.
    Biochem Pharmacol; 1999 Jan 15; 57(2):155-62. PubMed ID: 9890563
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.